Inhibitors to Von Willebrand Factor in Type 3 Von Willebrand Disease (VWD)

DOI: 10.26717/BJSTR.2017.01.000242

Received: July 20, 2017;   Published: August 01, 2017

To view the Full Article   Peer-reviewed Article PDF

Abstract

Type 3 VWD is the least common and most severe among the three types of VWD. The incidence was estimated at 5-3/million and the severity is thought to be similar to mild or moderate hemophilia A. In a recent report from the UK showing that some hemostasis laboratories may fail to perform all required assays for the diagnosis of VWD Type 3, which occasionally result in giving a wrong diagnosis such as mild or moderate hemophilia A. [1] Type 3 VWD is usually associated with a clinical course that combines the bleeding features seen in patients with VWD as well as those encountered in patients with mild to moderate hemophilia.

Introduction| Objectives| Methods| Results| Conclusion| References|